These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 37517504)

  • 1. Information about missing patient-reported outcome data in breast cancer trials is frequently not documented: a scoping review.
    Krepper D; Giesinger JM; Dirven L; Efficace F; Martini C; Thurner AMM; Al-Naesan I; Gross F; Sztankay MJ
    J Clin Epidemiol; 2023 Oct; 162():1-9. PubMed ID: 37517504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statistical analysis of patient-reported outcome data in randomised controlled trials of locally advanced and metastatic breast cancer: a systematic review.
    Pe M; Dorme L; Coens C; Basch E; Calvert M; Campbell A; Cleeland C; Cocks K; Collette L; Dirven L; Dueck AC; Devlin N; Flechtner HH; Gotay C; Griebsch I; Groenvold M; King M; Koller M; Malone DC; Martinelli F; Mitchell SA; Musoro JZ; Oliver K; Piault-Louis E; Piccart M; Pimentel FL; Quinten C; Reijneveld JC; Sloan J; Velikova G; Bottomley A;
    Lancet Oncol; 2018 Sep; 19(9):e459-e469. PubMed ID: 30191850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The current practice of handling and reporting missing outcome data in eight widely used PROMs in RCT publications: a review of the current literature.
    Rombach I; Rivero-Arias O; Gray AM; Jenkinson C; Burke Ó
    Qual Life Res; 2016 Jul; 25(7):1613-23. PubMed ID: 26821918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Informative value of Patient Reported Outcomes (PRO) in Health Technology Assessment (HTA).
    Brettschneider C; Lühmann D; Raspe H
    GMS Health Technol Assess; 2011 Feb; 7():Doc01. PubMed ID: 21468289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A review of the use of controlled multiple imputation in randomised controlled trials with missing outcome data.
    Tan PT; Cro S; Van Vogt E; Szigeti M; Cornelius VR
    BMC Med Res Methodol; 2021 Apr; 21(1):72. PubMed ID: 33858355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Localization techniques for guided surgical excision of non-palpable breast lesions.
    Chan BK; Wiseberg-Firtell JA; Jois RH; Jensen K; Audisio RA
    Cochrane Database Syst Rev; 2015 Dec; 2015(12):CD009206. PubMed ID: 26718728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statistical analysis and handling of missing data in cluster randomized trials: a systematic review.
    Fiero MH; Huang S; Oren E; Bell ML
    Trials; 2016 Feb; 17():72. PubMed ID: 26862034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Missing data were poorly reported and handled in randomized controlled trials with repeatedly measured continuous outcomes: a cross-sectional survey.
    Ren Y; Jia Y; Huang Y; Zhang Y; Li Q; Yao M; Li L; Li G; Yang M; Yan P; Wang Y; Zou K; Sun X
    J Clin Epidemiol; 2022 Aug; 148():27-38. PubMed ID: 35436523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inclusion of older patients with cancer in randomised controlled trials with patient-reported outcomes: a systematic review.
    Sparano F; Aaronson NK; Sprangers MAG; Fayers P; Pusic A; Kieffer JM; Cottone F; Rees J; Pezold M; Anota A; Charton E; Vignetti M; Wan C; Blazeby J; Efficace F
    BMJ Support Palliat Care; 2019 Dec; 9(4):451-463. PubMed ID: 31719051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Handling missing data in RCTs; a review of the top medical journals.
    Bell ML; Fiero M; Horton NJ; Hsu CH
    BMC Med Res Methodol; 2014 Nov; 14():118. PubMed ID: 25407057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A systematic evaluation of compliance and reporting of patient-reported outcome endpoints in ovarian cancer randomised controlled trials: implications for generalisability and clinical practice.
    Mercieca-Bebber R; Friedlander M; Calvert M; Stockler M; Kyte D; Kok PS; King MT
    J Patient Rep Outcomes; 2017; 1(1):5. PubMed ID: 29757300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality of patient-reported outcome reporting in randomised controlled trials of haematological malignancies according to international quality standards: a systematic review.
    Chakraborty R; Cannella L; Cottone F; Efficace F
    Lancet Haematol; 2020 Dec; 7(12):e892-e901. PubMed ID: 33242446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statistical Analysis Methods and Reporting of Patient-Reported Outcomes in Randomized Controlled Trials for Cancer Conducted in Japan: A Systematic Review.
    Mizusawa J; Ogawa G; Terada M; Ishiki H; Kikawa Y; Kiyota N
    Cureus; 2024 May; 16(5):e60804. PubMed ID: 38910767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Missing data strategies for the Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) in Alliance A091105 and COMET-2.
    Mazza GL; Petersen MM; Ginos B; Langlais BT; Heon N; Gounder MM; Mahoney MR; Zoroufy AJ; Schwartz GK; Rogak LJ; Thanarajasingam G; Basch E; Dueck AC
    Qual Life Res; 2022 Apr; 31(4):1069-1080. PubMed ID: 34420143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, implementation and reporting strategies to reduce the instance and impact of missing patient-reported outcome (PRO) data: a systematic review.
    Mercieca-Bebber R; Palmer MJ; Brundage M; Calvert M; Stockler MR; King MT
    BMJ Open; 2016 Jun; 6(6):e010938. PubMed ID: 27311907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient-reported outcomes in randomised clinical trials of bladder cancer: an updated systematic review.
    Van Hemelrijck M; Sparano F; Josephs D; Sprangers M; Cottone F; Efficace F
    BMC Urol; 2019 Sep; 19(1):86. PubMed ID: 31521149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient-reported outcomes in randomised controlled trials of prostate cancer: methodological quality and impact on clinical decision making.
    Efficace F; Feuerstein M; Fayers P; Cafaro V; Eastham J; Pusic A; Blazeby J;
    Eur Urol; 2014 Sep; 66(3):416-27. PubMed ID: 24210091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient-Important Outcomes Other Than Mortality in Contemporary ICU Trials: A Scoping Review.
    Granholm A; Anthon CT; Kjær MN; Maagaard M; Kaas-Hansen BS; Sivapalan P; Schjørring OL; Andersen LW; Mathiesen O; Strøm T; Jensen AKG; Perner A; Møller MH
    Crit Care Med; 2022 Oct; 50(10):e759-e771. PubMed ID: 35894598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.